Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Gene expression profiling reveals two overarching types of ALCL with distinct targetable biology: an LLMPP study

Andrew L. Feldman, Surendra Dasari, Lisa M. Rimsza, David W. Scott, Naoki Oishi, Guangzhen Hu, Pedro Farinha, Catalina Amador, Elías Campo, Wing C. Chan, James R. Cook, Jan Delabie, Kai Fu, Timothy C Greiner, Laura K Hilton, Giorgio GA Inghirami, Javeed Iqbal, Elaine S Jaffe, Ryan Morin, Sarah L. Ondrejka, German Ott, Stefania Pittaluga, Philipp W Raess, Andreas Rosenwald, Kerry J. Savage, Graham W. Slack, Susan L. Slager, Joo Y Song, George Wright, Hao-Wei Wang, Yu Zeng, Tadashi Yoshino, Xiaojun Wu, Ryan A Wilcox, xueju wang, Min Shi, Akira Satou, Anamarija M Perry, Roberto Nicolas Miranda, L.Jeffrey Jeffrey Medeiros, Matthew J Maurer, Eric Mou, Young Hyeh Ko, Kennosuke Karube, Brad S Kahl, Liuyan Jiang, David L Jaye, Alejandro Gru, Laurence L de Leval, Weina Chen, Jennifer R. Chapman, James R Cerhan, Carlos Barrionuevo, Stephen M. Ansell, Ahmed Aljudi

Blood blood.2024027700.

https://doi.org/10.1182/blood.2024027700

Published: 2025

Includes: Supplemental data

Journal Articles

Artificial intelligence accelerates the identification of measurable residual multiple myeloma by flow cytometry

Clarissa Jordan, Matthew Weybright, Dragan Jevremovic, Min Shi, April Chiu, Michael Timm, Gregory Otteson, Horatiu Olteanu, Jansen Seheult, Pedro Horna

Blood (2025) 146 (Supplement 1): 2224.

https://doi.org/10.1182/blood-2025-2224

Published: 2025

Journal Articles

Venetoclax-obinutuzumab in frontline and R/R CLL: Outcomes compared to age- and sex-matched general population

Blood (2025) 146 (Supplement 1): 3905.

https://doi.org/10.1182/blood-2025-3905

Published: 2025

Journal Articles

Genetic analysis of B and T cell subsets from CLL patients prior to and at Richter's transformation

Sutapa Sinha, Panwen Wang, Hugues Sicotte, Brianna Finke, Heather Darby, Elijah Blonigen, Miles Del Busso, Zhiquan Wang, Min Shi, Sameer Parikh, Wei Ding, Saad Kenderian, Neil Kay

Blood (2025) 146 (Supplement 1): 2099.

https://doi.org/10.1182/blood-2025-2099

Published: 2025

Journal Articles

Pirtobrutinib versus usual care for patients with richter transformation of chronic lymphocytic leukemia: Inverse probability of treatment weighting-based analysis of BRUIN trial and mayo observational cohort

Yucai Wang, Kari Rabe, Paul Hampel, Lindsey Roeker, Jihao Zhou, Suheil Albert Atallah-Yunes, Susan Schwager, Min Shi, Curtis Hanson, Rebecca King, Cinthya Mendoza Zepeda, Saad Kenderian, Eli Muchtar, Neil Kay, Amber Koehler, Amy Behnken, Catherine Coddington, Susan Slager, Sameer Parikh

Blood (2025) 146 (Supplement 1): 5673.

https://doi.org/10.1182/blood-2025-5673

Published: 2025

Journal Articles

Progression of disease within 36 months (POD36) of starting first-line targeted therapy independently predicts poor overall survival in patients with chronic lymphocytic leukemia (CLL)

Blood (2025) 146 (Supplement 1): 5667.

https://doi.org/10.1182/blood-2025-5667

Published: 2025

Journal Articles

T-large granular lymphocytic leukemia transformation to peripheral T-cell lymphoma

Min Shi, Karen L. Rech

Blood (2025) 146 (15): 1868.

https://doi.org/10.1182/blood.2025030173

Published: 2025

Journal Articles

Artificial Intelligence-Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual Chronic Lymphocytic Leukemia

April Chiu, Jansen N Seheult, Min Shi, Dragan Jevremovic, Matthew J Weybright, Michael M Timm, Gregory E Otteson, Horatiu Olteanu, Pedro Horna

Blood (2024) 144 (Supplement 1): 1858.

https://doi.org/10.1182/blood-2024-199901

Published: 2024

Journal Articles

Artificial Intelligence-Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual B Lymphoblastic Leukemia

Jansen N Seheult, Matthew J Weybright, Min Shi, Dragan Jevremovic, April Chiu, Michael M Timm, Gregory E Otteson, Horatiu Olteanu, Pedro Horna

Blood (2024) 144 (Supplement 1): 4226.

https://doi.org/10.1182/blood-2024-199894

Published: 2024

Journal Articles

BCL2 Expression Correlates with New Molecular Classification of Anaplastic Large Cell Lymphoma

Jimena B. Gimenez, Min Shi, Naoki Oishi, Liuyan Jiang, Farah M. Salama, Jennifer R. Chapman-Fredricks, Weina Chen, Jagmohan Sidhu, Xiaojun Wu, Stephen M. Ansell, Guangzhen Hu, Andrew L. Feldman

Blood (2024) 144 (Supplement 1): 4381.

https://doi.org/10.1182/blood-2024-208516

Published: 2024

Journal Articles

The Fusion Landscape of Anaplastic Large Cell Lymphoma: An L.L.M.P.P. Study

Andrew L. Feldman, Guangzhen Hu, Surendra Dasari, Lisa M. Rimsza, David W. Scott, Jimena B. Gimenez, Farah M. Salama, Min Shi, Elías Campo, Wing Chung Chan, James R. Cook, Giorgio Inghirami, Elaine S. Jaffe, Ryan Morin, Phillipp W. Raess, Andreas Rosenwald, Kerry J. Savage, Louis M. Staudt, George W. Wright, Catalina Amador, Jan Delabie, Timothy C. Greiner, Javeed Iqbal, Laura K. Hilton, Sarah L. Ondrejka, German Ott, Stefania Pittaluga, Graham W. Slack, Susan L. Slager, Joo Y. Song, Hao-Wei Wang, Ahmed A. Aljudi, Stephen M. Ansell, Carlos Barrionuevo, James R. Cerhan, Jennifer R. Chapman-Fredricks, Weina Chen, Laurence de Leval, Alejandro A. Gru, David L. Jaye, Liuyan Jiang, Brad S. Kahl, Kennosuke Karube, Young Hyeh Ko, Eric Mou, Matthew J. Maurer, L. Jeffrey Medeiros, Roberto N. Miranda, Naoki Oishi, Perry M. Anamarija, Akira Satou, Xueju Wang, Ryan A. Wilcox, Xiaojun Wu, Tadashi Yoshino, Yu Zeng

Blood (2024) 144 (Supplement 1): 2974.

https://doi.org/10.1182/blood-2024-202410

Published: 2024

Journal Articles

Tigit: The Potential Mechanisms of Relapse in Multiple Myeloma Following Anti-BCMA CAR-T Therapy and a Promising Target for Improving CAR-T Efficacy

Yuan Xia, Xuxing Shen, Min Shi, Na Shen, Yu Zhu, Lei Fan, Jianyong Li, Lijuan Chen

Blood (2024) 144 (Supplement 1): 2033.

https://doi.org/10.1182/blood-2024-205126

Published: 2024

Journal Articles

Outcomes of Patients with Small Lymphocytic Lymphoma (SLL) Receiving First Line Treatment

Blood (2023) 142 (Supplement 1): 3284.

https://doi.org/10.1182/blood-2023-181866

Published: 2023

Journal Articles

PD-1 Expression in Lymphoma Cells Mediates Cellular Proliferation By Engaging Phosphatase SHP-1/SHP-2

Blood (2023) 142 (Supplement 1): 3261.

https://doi.org/10.1182/blood-2023-177755

Published: 2023

Journal Articles

Clinical Outcomes with Venetoclax-Based Treatment Regimens in Patients with Chronic Lymphocytic Leukemia (CLL)

Blood (2023) 142 (Supplement 1): 3276.

https://doi.org/10.1182/blood-2023-183007

Published: 2023

Journal Articles

Machine Learning Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual Acute Myeloid Leukemia

Jansen N Seheult, Min Shi, Horatiu Olteanu, Gregory E Otteson, Michael M Timm, Matthew J Weybright, Pedro Horna

Blood (2023) 142 (Supplement 1): 4339.

https://doi.org/10.1182/blood-2023-190275

Published: 2023

Journal Articles

Chronic Lymphoproliferative Disorder of Natural Killer Cells: Patient Characteristics, Laboratory Features, and Clinical Outcomes

Richard C. Godby, Kari G. Rabe, Steven R. Hwang, Hadiyah Audil, Susan L. Slager, Saad S. Kenderian, Neil E. Kay, Yucai Wang, Paul J Hampel, Sameer A. Parikh, Wei Ding, Min Shi

Blood (2023) 142 (Supplement 1): 4446.

https://doi.org/10.1182/blood-2023-182545

Published: 2023

Journal Articles

Incidence of Richter Transformation in Patients with Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL): A Cohort Study Evaluating Different Therapeutic Eras

Blood (2023) 142 (Supplement 1): 3271.

https://doi.org/10.1182/blood-2023-185076

Published: 2023

Journal Articles

Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients

Blood (2023) 141 (9): 1036–1046.

https://doi.org/10.1182/blood.2021013489

Published: 2023

Includes: Supplemental data

Journal Articles

Improved semiautomated detection of TRBC-restricted Sézary cells unveils a spectrum of clonal cluster immunophenotypes

Pedro Horna, Gregory Otteson, Min Shi, Jansen N. Seheult, Dragan Jevremovic, Horatiu Olteanu

Blood (2022) 140 (26): 2852–2856.

https://doi.org/10.1182/blood.2022017548

Published: 2022

Includes: Supplemental data

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Gene expression profiling reveals two overarching types of ALCL with distinct targetable biology: an LLMPP study

Artificial intelligence accelerates the identification of measurable residual multiple myeloma by flow cytometry

Venetoclax-obinutuzumab in frontline and R/R CLL: Outcomes compared to age- and sex-matched general population

Genetic analysis of B and T cell subsets from CLL patients prior to and at Richter's transformation

Pirtobrutinib versus usual care for patients with richter transformation of chronic lymphocytic leukemia: Inverse probability of treatment weighting-based analysis of BRUIN trial and mayo observational cohort

Progression of disease within 36 months (POD36) of starting first-line targeted therapy independently predicts poor overall survival in patients with chronic lymphocytic leukemia (CLL)

T-large granular lymphocytic leukemia transformation to peripheral T-cell lymphoma

Artificial Intelligence-Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual Chronic Lymphocytic Leukemia

Artificial Intelligence-Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual B Lymphoblastic Leukemia

BCL2 Expression Correlates with New Molecular Classification of Anaplastic Large Cell Lymphoma

The Fusion Landscape of Anaplastic Large Cell Lymphoma: An L.L.M.P.P. Study

Tigit: The Potential Mechanisms of Relapse in Multiple Myeloma Following Anti-BCMA CAR-T Therapy and a Promising Target for Improving CAR-T Efficacy

Outcomes of Patients with Small Lymphocytic Lymphoma (SLL) Receiving First Line Treatment

PD-1 Expression in Lymphoma Cells Mediates Cellular Proliferation By Engaging Phosphatase SHP-1/SHP-2

Clinical Outcomes with Venetoclax-Based Treatment Regimens in Patients with Chronic Lymphocytic Leukemia (CLL)

Machine Learning Enhancement of Flow Cytometry Data Accelerates the Identification of Minimal Residual Acute Myeloid Leukemia

Chronic Lymphoproliferative Disorder of Natural Killer Cells: Patient Characteristics, Laboratory Features, and Clinical Outcomes

Incidence of Richter Transformation in Patients with Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL): A Cohort Study Evaluating Different Therapeutic Eras

Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients

Improved semiautomated detection of TRBC-restricted Sézary cells unveils a spectrum of clonal cluster immunophenotypes

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only